Rezultati pretrage - Ronit Simantov

Detaljiziraj rezultate
  1. 1
    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 od Ronit Simantov, Maria Febbraio, René Crombie, Adam S. Asch, Ralph L. Nachman, Roy L. Silverstein

    Izdano 2001
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

    Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database od André P. Fay, Rana R. McKay, Xun Lin, Ronit Simantov, Toni K. Choueiri

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II

    High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II od Keying Ma, Ronit Simantov, Jing-Chuan Zhang, Roy L. Silverstein, Katherine A. Hajjar, Keith R. McCrae

    Izdano 2000
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma

    Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients with Renal Cell Carcinoma od Rana R. McKay, Xun Lin, Julia Jane Perkins, Daniel Y.C. Heng, Ronit Simantov, Toni K. Choueiri

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

    Activation of cultured vascular endothelial cells by antiphospholipid antibodies. od Ronit Simantov, J M LaSala, S K Lo, A E Gharavi, Lisa R. Sammaritano, Jane E. Salmon, Roy L. Silverstein

    Izdano 1995
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma

    Depth of Remission is a Prognostic Factor for Survival in Patients with Metastatic Renal Cell Carcinoma od Viktor Grünwald, Rana R. McKay, Katherine M. Krajewski, D. Kalanovic, Xun Lin, Julia Jane Perkins, Ronit Simantov, Toni K. Choueiri

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

    Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo od Ling Qi, Andrew T. Jacovina, Arunkumar B. Deora, Maria Febbraio, Ronit Simantov, Roy L. Silverstein, Barbara Hempstead, Willie Mark, Katherine A. Hajjar

    Izdano 2004
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma

    Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma od Rana R. McKay, Gustavo E. Rodriguez, Xun Lin, Marina D. Kaymakcalan, Ole‐Petter R. Hamnvik, Venkata Sabbisetti, Rupal S. Bhatt, Ronit Simantov, Toni K. Choueiri

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice

    Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice od Hayes M. Dansky, Sherri A. Charlton, John L. Sikes, Simon Heath, Ronit Simantov, Lawrence F. Levin, Pei Shu, Karen J. Moore, Jan L. Breslow, Jonathan D. Smith

    Izdano 1999
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors

    A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors od Igor Puzanov, Colin R. Lindsay, Laura W. Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T.R. Jeffry Evans

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer

    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer od Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph S. Marks, Joel R. Reid, Gary A. Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer

    Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer od April A. N. Rose, Andrée‐Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia MacDonald, Nicholas Bertos, Yves St‐Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury, Peter M. Siegel

    Izdano 2010
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors

    Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors od Robin L. Jones, Edward S. Kim, Pilar Nava-Parada, Salma Alam, Faye M. Johnson, Andrew Stephens, Ronit Simantov, Srinivasu Poondru, Rich Gedrich, Scott M. Lippman, Stan B. Kaye, Craig P. Carden

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus

    Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus od Mary J. Roman, Beth‐Ann Shanker, Adrienne Davis, Michael D. Lockshin, Lisa R. Sammaritano, Ronit Simantov, Mary K. Crow, Joseph E. Schwartz, Stephen A. Paget, Richard B. Devereux, Jane E. Salmon

    Izdano 2003
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Statins and survival outcomes in patients with metastatic renal cell carcinoma

    Statins and survival outcomes in patients with metastatic renal cell carcinoma od Rana R. McKay, Xun Lin, Laurence Albigès, André P. Fay, Marina D. Kaymakcalan, Suzanne S Mickey, P. Peter Ghoroghchian, Rupal S. Bhatt, Samuel Kaffenberger, Ronit Simantov, Toni K. Choueiri, Daniel Yick Chin Heng

    Izdano 2015
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma od Patrick A. Ott, Omid Hamid, Anna C. Pavlick, Harriet M. Kluger, Kevin B. Kim, Peter D. Boasberg, Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, Thomas A. Davis, Mario Sznol, Patrick Hwu

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

    Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer od Johanna C. Bendell, Mansoor N. Saleh, April A. N. Rose, Peter M. Siegel, Lowell L. Hart, Surendra Sirpal, Suzanne F. Jones, Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, Thomas A. Davis, Linda T. Vahdat

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis od Tim Eisen, T. Ahmad, Keith T. Flaherty, Martin Gore, Stan B. Kaye, Richard Marais, I. Gibbens, Samuel Hackett, Maggie James, Lynn M. Schuchter, Katherine L. Nathanson, Chenjing Xia, Ronit Simantov, Brian Schwartz, Melanie Poulin-Costello, Peter J. O’Dwyer, Mark J. Ratain

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma

    Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma od Aly‐Khan A. Lalani, Wanling Xie, David A. Braun, Marina D. Kaymakcalan, Dominick Bossé, John A. Steinharter, Dylan J. Martini, Ronit Simantov, Xun Lin, Xiao X. Wei, Bradley A. McGregor, Rana R. McKay, Lauren C. Harshman, Toni K. Choueiri

    Izdano 2019
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

    Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma od Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, M. Siebels, Sylvie Négrier, Christine Chevreau, E Solska, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sara M. Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M. Bukowski

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: